1. Home
  2. SLRX vs RAYA Comparison

SLRX vs RAYA Comparison

Compare SLRX & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • RAYA
  • Stock Information
  • Founded
  • SLRX N/A
  • RAYA 2019
  • Country
  • SLRX United States
  • RAYA China
  • Employees
  • SLRX N/A
  • RAYA N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • SLRX Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • SLRX 3.6M
  • RAYA 4.3M
  • IPO Year
  • SLRX N/A
  • RAYA 2022
  • Fundamental
  • Price
  • SLRX $3.21
  • RAYA $3.78
  • Analyst Decision
  • SLRX
  • RAYA
  • Analyst Count
  • SLRX 0
  • RAYA 0
  • Target Price
  • SLRX N/A
  • RAYA N/A
  • AVG Volume (30 Days)
  • SLRX 197.9K
  • RAYA 59.5K
  • Earning Date
  • SLRX 11-10-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • SLRX N/A
  • RAYA N/A
  • EPS Growth
  • SLRX N/A
  • RAYA N/A
  • EPS
  • SLRX N/A
  • RAYA N/A
  • Revenue
  • SLRX N/A
  • RAYA $30,300,360.00
  • Revenue This Year
  • SLRX N/A
  • RAYA $20.95
  • Revenue Next Year
  • SLRX N/A
  • RAYA N/A
  • P/E Ratio
  • SLRX N/A
  • RAYA N/A
  • Revenue Growth
  • SLRX N/A
  • RAYA 49.10
  • 52 Week Low
  • SLRX $3.16
  • RAYA $3.65
  • 52 Week High
  • SLRX $108.00
  • RAYA $737.00
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 37.04
  • RAYA 45.02
  • Support Level
  • SLRX $3.55
  • RAYA $4.80
  • Resistance Level
  • SLRX $3.97
  • RAYA $5.00
  • Average True Range (ATR)
  • SLRX 0.31
  • RAYA 0.40
  • MACD
  • SLRX -0.07
  • RAYA -0.37
  • Stochastic Oscillator
  • SLRX 3.72
  • RAYA 4.45

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: